Renewal of Charter for the Advisory Committee on Blood Safety and Availability, 71444 [2010-29518]

Download as PDF 71444 Federal Register / Vol. 75, No. 225 / Tuesday, November 23, 2010 / Notices Health and Human Services approved for the Committee charter to be renewed. The new charter was effected and filed with the appropriate Congressional offices and Library of Congress on October 1, 2010. Renewal of the SACHRP charter provides authorization for the Committee to operate until October 1, 2012. A copy of the Committee charter is available on the SACHRP Web site at https://www.hhs.gov/ohrp/sachrp/ charter.htm. A copy of the Committee charter also can be obtained by accessing the FACA database that is maintained by the Committee Management Secretariat under the General Services Administration. The Web site address for the FACA database is https://fido.gov/facadatabase. Dated: November 16, 2010. Jerry Menikoff, Director, Office for Human Research Protections, and Executive Secretary, Secretary’s Advisory Committee on Human Research Protections. [FR Doc. 2010–29517 Filed 11–22–10; 8:45 am] BILLING CODE 4150–36–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Renewal of Charter for the Advisory Committee on Blood Safety and Availability Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, as amended (5 U.S.C. App), the U.S. Department of Health and Human Services is hereby announcing renewal of the charter for the Advisory Committee on Blood Safety and Availability (ACBSA). FOR FURTHER INFORMATION CONTACT: Jerry Holmberg, PhD; Senior Advisor for Blood Policy and Executive Secretary, Advisory Committee on Blood Safety and Availability; Department of Health and Human Services; 1101 Wootton Parkway; Tower Building, Suite 250; Rockville, MD 20852; Telephone: (240) 453–8803; Fax: (240) 453–8456; E-mail address: acbsa@hhs.gov. SUPPLEMENTARY INFORMATION: ACBSA was established in 1996. The Committee provides advice and guidance to the Secretary, through the Assistant Secretary for Health, on a range of blood safety issues that encompass broad public health and societal implications that cannot be resolved through analysis of scientific data alone. The range of mstockstill on DSKH9S0YB1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 18:02 Nov 22, 2010 Jkt 223001 issues on which the Committee is tasked to provide advice and guidance includes, but is not limited to: (1) Definition of public health parameters around safety and availability of the blood and blood products; (2) broad public health, ethical, and legal issues related to transfusion and transplantation safety; and (3) implications for safety and availability of various economic factors affecting product cost and supply. Since the ACBSA was established, renewal of the Committee charter has been carried out at the appropriate intervals as stipulated by FACA. The previous Committee charter was scheduled to expire on October 9, 2010. On October 8, 2010, the Secretary of Health and Human Services approved for the Committee charter to be renewed. The new charter was effected and filed with the appropriate Congressional offices and Library of Congress on October 9, 2010. Renewal of the ACBSA charter provides authorization for the Committee to operate until October 9, 2012. A copy of the Committee charter is available on the ACBSA Web site at https://www.hhs.gov/ash/bloodsafety/. A copy of the Committee charter also can be obtained by accessing the FACA database that is maintained by the Committee Management Secretariat under the General Services Administration. The Web site address for the FACA database is https://fido.gov/ facadatabase. Dated: November 17, 2010. Jerry A. Holmberg, Senior Advisor for Blood Policy, Executive Secretary, Advisory Committee on Blood Safety and Availability. [FR Doc. 2010–29518 Filed 11–22–10; 8:45 am] BILLING CODE 4150–41–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0422] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Information From United States Firms and Processors That Export to the European Community AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a proposed collection of SUMMARY: PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by December 23, 2010. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202–395–7285, or e-mailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910–0320. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400B, Rockville, MD 20850, 301–796– 3793. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Information From United States Firms and Processors That Export to the European Community (OMB Control Number 0910–0320)—Revision The European Community (EC) is a group of 27 European countries that have agreed to harmonize their commodity requirements to facilitate commerce among member States. EC legislation for intra-EC trade has been extended to trade with non-EC countries, including the United States. For certain food products, including those listed in this document, EC legislation requires assurances from the responsible authority of the country of origin that the processor of the food is in compliance with applicable regulatory requirements. The European Commission, the executive branch of the EC, requires countries trading with any of the EC member countries to provide lists of firms and processors approved to export certain animalderived commodities to the EC. As stated in the notice published in the Federal Register of April 4, 1996 (61 FR 15077), FDA established a list of U.S. firms and processors that intended to export shell eggs, dairy products, and game meat and game meat products to the EC. Although the 1996 Federal Register notice did not include on the list firms and processors exporting raw, bulk collagen, and gelatin intended for E:\FR\FM\23NON1.SGM 23NON1

Agencies

[Federal Register Volume 75, Number 225 (Tuesday, November 23, 2010)]
[Notices]
[Page 71444]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-29518]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Renewal of Charter for the Advisory Committee on Blood Safety and 
Availability

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), the U.S. Department of Health and Human 
Services is hereby announcing renewal of the charter for the Advisory 
Committee on Blood Safety and Availability (ACBSA).

FOR FURTHER INFORMATION CONTACT: Jerry Holmberg, PhD; Senior Advisor 
for Blood Policy and Executive Secretary, Advisory Committee on Blood 
Safety and Availability; Department of Health and Human Services; 1101 
Wootton Parkway; Tower Building, Suite 250; Rockville, MD 20852; 
Telephone: (240) 453-8803; Fax: (240) 453-8456; E-mail address: 
acbsa@hhs.gov.

SUPPLEMENTARY INFORMATION: ACBSA was established in 1996. The Committee 
provides advice and guidance to the Secretary, through the Assistant 
Secretary for Health, on a range of blood safety issues that encompass 
broad public health and societal implications that cannot be resolved 
through analysis of scientific data alone. The range of issues on which 
the Committee is tasked to provide advice and guidance includes, but is 
not limited to: (1) Definition of public health parameters around 
safety and availability of the blood and blood products; (2) broad 
public health, ethical, and legal issues related to transfusion and 
transplantation safety; and (3) implications for safety and 
availability of various economic factors affecting product cost and 
supply.
    Since the ACBSA was established, renewal of the Committee charter 
has been carried out at the appropriate intervals as stipulated by 
FACA. The previous Committee charter was scheduled to expire on October 
9, 2010. On October 8, 2010, the Secretary of Health and Human Services 
approved for the Committee charter to be renewed. The new charter was 
effected and filed with the appropriate Congressional offices and 
Library of Congress on October 9, 2010. Renewal of the ACBSA charter 
provides authorization for the Committee to operate until October 9, 
2012.
    A copy of the Committee charter is available on the ACBSA Web site 
at https://www.hhs.gov/ash/bloodsafety/. A copy of the Committee charter 
also can be obtained by accessing the FACA database that is maintained 
by the Committee Management Secretariat under the General Services 
Administration. The Web site address for the FACA database is https://fido.gov/facadatabase.

    Dated: November 17, 2010.
Jerry A. Holmberg,
Senior Advisor for Blood Policy, Executive Secretary, Advisory 
Committee on Blood Safety and Availability.
[FR Doc. 2010-29518 Filed 11-22-10; 8:45 am]
BILLING CODE 4150-41-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.